BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28861636)

  • 21. How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study.
    Gonnelli S; Caffarelli C; Rossi S; Di Munno O; Malavolta N; Isaia G; Muratore M; D'Avola G; Gatto S; Minisola G; Nuti R
    Aging Clin Exp Res; 2016 Jun; 28(3):459-68. PubMed ID: 26873817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU study.
    Roux C; Cooper C; Díez-Pérez A; Martinez L; Ortolani S; Gitlin M; Möller G; Shepherd S; Freemantle N
    Osteoporos Int; 2011 Apr; 22(4):1227-36. PubMed ID: 20628731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.
    Fahrleitner-Pammer A; Papaioannou N; Gielen E; Feudjo Tepie M; Toffis C; Frieling I; Geusens P; Makras P; Boschitsch E; Callens J; Anastasilakis AD; Niedhart C; Resch H; Kalouche-Khalil L; Hadji P
    Arch Osteoporos; 2017 Dec; 12(1):58. PubMed ID: 28643265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
    Dennison EM; Compston JE; Flahive J; Siris ES; Gehlbach SH; Adachi JD; Boonen S; Chapurlat R; Díez-Pérez A; Anderson FA; Hooven FH; LaCroix AZ; Lindsay R; Netelenbos JC; Pfeilschifter J; Rossini M; Roux C; Saag KG; Sambrook P; Silverman S; Watts NB; Greenspan SL; Premaor M; Cooper C;
    Bone; 2012 Jun; 50(6):1288-93. PubMed ID: 22426498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study.
    Modi A; Sen S; Adachi JD; Adami S; Cortet B; Cooper AL; Geusens P; Mellström D; Weaver JP; van den Bergh JP; Keown P; Sajjan S
    Osteoporos Int; 2018 Feb; 29(2):329-337. PubMed ID: 29110061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the validity of osteoporosis and fracture risk assessment tools (IOF One Minute Test, SCORE, and FRAX) in postmenopausal Palestinian women.
    Kharroubi A; Saba E; Ghannam I; Darwish H
    Arch Osteoporos; 2017 Dec; 12(1):6. PubMed ID: 28013446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of pharmacotherapy in postmenopausal osteoporosis: a longitudinal observational study.
    Pluskiewicz W; Adamczyk P; Franek E; Sewerynek E; Wichrowska H; Napiórkowska L; Stuss M; Rozwandowicz A; Drozdzowska B
    Endokrynol Pol; 2019; 70(6):473-477. PubMed ID: 31909456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway.
    Hoff M; Meyer HE; Skurtveit S; Langhammer A; Søgaard AJ; Syversen U; Dhainaut A; Skovlund E; Abrahamsen B; Schei B
    Osteoporos Int; 2017 Oct; 28(10):2935-2944. PubMed ID: 28668994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
    Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autonomy begets adherence: decisions to start and persist with osteoporosis treatment after group medical consultation.
    Wilton-Clark MS; Feasel AL; Kline GA; Billington EO
    Arch Osteoporos; 2020 Sep; 15(1):138. PubMed ID: 32888079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fracture risk perception study: patient self-perceptions of bone health often disagree with calculated fracture risk.
    Grover ML; Edwards FD; Chang YH; Cook CB; Behrens MC; Dueck AC
    Womens Health Issues; 2014; 24(1):e69-75. PubMed ID: 24439949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does osteoporosis therapy invalidate FRAX for fracture prediction?
    Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
    J Bone Miner Res; 2012 Jun; 27(6):1243-51. PubMed ID: 22392538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model.
    Ni W; Jiang Y
    Osteoporos Int; 2017 Feb; 28(2):529-538. PubMed ID: 27581955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fracture risk among treatment-naïve postmenopausal women with osteopenia in Greece: results from the "ACROSS" study.
    Anastasilakis AD; Makras P
    Arch Osteoporos; 2020 Oct; 15(1):163. PubMed ID: 33067646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Su Y; Leung J; Kwok T
    Osteoporos Int; 2018 Feb; 29(2):355-363. PubMed ID: 29067485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Kanis JA; McCloskey EV; Johansson H; Cooper C; Rizzoli R; Reginster JY;
    Osteoporos Int; 2013 Jan; 24(1):23-57. PubMed ID: 23079689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Denosumab utilization among older adults in Ontario: patient characteristics, persistence with therapy, and return to therapy after an extended gap.
    Ban JK; Hao BB; McCarthy L; Guilcher SJT; Cadarette SM
    Osteoporos Int; 2019 Sep; 30(9):1865-1872. PubMed ID: 31317248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A discussion of the intervention thresholds in osteoporosis treatment in Poland.
    Marcinkowska M; Ignaszak-Szczepaniak M; Wawrzyniak A; Dytfeld J; Marcinkowska WH; Ignaszak-Szczepaniak M; Wawrzyniak A; Dytfeld J; Horst-Sikorska W
    Endokrynol Pol; 2011; 62(1):30-6. PubMed ID: 21365576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Worldwide Fracture Prediction.
    El-Hajj Fuleihan G; Chakhtoura M; Cauley JA; Chamoun N
    J Clin Densitom; 2017; 20(3):397-424. PubMed ID: 28734709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review.
    Fujiwara S; Miyauchi A; Hamaya E; Nicholls RJ; Weston A; Baidya S; Pinto L; Barron R; Takada J
    Arch Osteoporos; 2018 Mar; 13(1):34. PubMed ID: 29564555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.